Skip to main content

Table 3 Overview of selected patient-reported outcome measures in axSpA across registries

From: Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

Registry

Patient global assessment

Patient pain assessment

Patient fatigue assessment

BASDAI/BASFI

Wordinga

Scaleb

Wordinga

Scaleb

Wordinga

Scaleb

Registered

Scaleb

ATTRA (Czechia)

Please indicate below how you feel when you consider all the ways in which your illness now affects you

VAS and NRS (0–100)

How much pain has your illness caused you DURING THE PAST WEEK?

NRS (0–100)

How much of a problem has unsual fatigue been for you DURING THE PAST WEEK?

NRS (0–100)

Yes/yes [25]

VAS

DANBIO (Denmark)

How does the arthritis affect your overall life at the moment?

VAS

How much pain due to arthritis do you have at the moment?

VAS

How tired are you at the moment?

VAS

Yes/yes [26]

VAS

ESRBTR (Estonia)

Patient´s evaluation of disease activity on a VAS ranging from “no activity” to “very active”.

VAS

Patient´s evaluation of pain on a VAS ranging from “no pain” to “strong pain”.

VAS

-

-

Yes/no

NRS

ROBFIN (Finland)

How is your health condition today?

VAS ranging from “very good to “worst possible”

VAS

How much pain have you been experiencing during last week?

VAS

How much fatigue have you been experiencing during last week?

VAS

Yes/yes [27]

VAS

ICEBIO (Iceland)

Put a mark on the line below which illustrates the disease activity on your health due to your disease during the last week

VAS

Put a mark on the line below which illustrates the pain due to your disease during the last week

VAS

Put a mark on the line below which illustrates the fatigue due to your disease during the last week

VAS

Yes/yes

VAS

GISEA (Italy)

Considering all the ways your arthritis has affected you, how active do you feel your arthritis is today on a scale ranging from 0 to 100?

NRS 0–100

Numerical rating scale ranging from 0 (no pain) to 100 (worst imaginable pain) measuring actual pain intensity during the last 24 hours

NRS 0–100

-

-

Yes/yes

VAS

AmSpA (Netherlands)

How active was your disease the last week?

NRS

How much back pain did you have during the night the last week?

NRS

How tired were you the last week?

-

Yes/yes

VAS

NOR-DMARD (Norway)

We kindly ask you to evaluate the activity in your arthritis during the last week. Considering all the symptoms you have had, how would you evaluate your condition?

VAS

How much pain have you had during the last week?

VAS

To what degree has a feeling of unusual tiredness or exhaustion been a problem for you during the last week?

VAS

Yes/no

VAS

Reuma.pt (Portugal)

Considering the way the disease disturbs you, how did you feel during the last week?

NRS and VAS

Please indicate the level of pain that you felt in your spine at any moment (day or night) during last week

VAS

FACIT questionnaire

-

Yes/yes [28]

VAS

RRBR (Romania)

Please rate how much the disease is globally affecting you, taking into account all the aspects of the disease (e.g., psoriasis and arthritis) over the past week

NRS

c

-

d

-

Yes/no

VAS

Biorx.si (Slovenia)

How does your disease affect you today?

NRS

How severe was the pain in the past week?

NRS

-

-

Yes/yes

NRS

BIOBADASER (Spain)

No specific wording, depends on each center

NRS

-

-

-

-

Yes/no [29]

VAS

SRQ (Sweden)

How have you felt in the last week, in general, given your rheumatic disease?

VAS

How much pain have you had in the last week due to your rheumatic disease?

VAS

How tired have you been in the last week due to your rheumatic disease?

VAS

Yes/yes [30, 31]

VAS

SCQM (Switzerland)

How active is your disease today?

NRS

How would you rate your overall pain in the past 7 days?

NRS

d

-

Yes/yes

VAS

BSRBR-AS (UK)

Bath Ankylosing Spondylitis Global Score (BAS-G)

-

Pain question in SF12, EQ5D, pain 100 mm VAS

-

Chalder Fatigue Scale

-

Yes/yes [32, 33]

VAS

  1. NRS Numeric rating scale from 0 to 10 unless stated otherwise, VAS Visual analog scale from 0 to 100 mm, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index
  2. aThe wording is based on a translation from the original language (if not English) in the online survey and follow-up interviews
  3. bScales are evaluated visually using graphic presentation of the respective patient assessments in secondary anonymized baseline data from initiation of the first biologic (b) or targeted synthetic (ts) disease-modifying anti-rheumatic drug (DMARD) treatment on patients with a clinical diagnosis of axial spondyloarthritis, 18 years or older, followed in one of the participating registries since the start of their first b/tsDMARD between 2000 to 2021. Sweden has provided data on Secukinumab treated patients only
  4. cBASDAI pain question
  5. dBASDAI fatigue question